newsfilter
← Latest News
GlobeNewswire·

Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments

SAN CARLOS, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ:BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform